Molina Healthcare (MOH)
(Delayed Data from NYSE)
$327.48 USD
-3.64 (-1.10%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $327.85 +0.37 (0.11%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth A Momentum B VGM
Income Statements
Fiscal Year end for Molina Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 34,072 | 31,974 | 27,771 | 19,423 | 16,829 |
Cost Of Goods | 28,669 | 27,175 | 23,704 | 15,820 | 13,905 |
Gross Profit | 5,403 | 4,799 | 4,067 | 3,603 | 2,924 |
Selling & Adminstrative & Depr. & Amort Expenses | 3,830 | 3,626 | 3,047 | 2,525 | 1,880 |
Income After Depreciation & Amortization | 1,573 | 1,173 | 1,020 | 1,078 | 1,044 |
Non-Operating Income | 0 | 0 | -25 | -15 | 15 |
Interest Expense | 109 | 110 | 120 | 102 | 87 |
Pretax Income | 1,464 | 1,063 | 875 | 961 | 972 |
Income Taxes | 373 | 271 | 216 | 288 | 235 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 1,091 | 792 | 659 | 673 | 737 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 1,091 | 792 | 659 | 673 | 737 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,744 | 1,349 | 1,151 | 1,166 | 1,138 |
Depreciation & Amortization (Cash Flow) | 171 | 176 | 131 | 88 | 94 |
Income After Depreciation & Amortization | 1,573 | 1,173 | 1,020 | 1,078 | 1,044 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 58.10 | 58.50 | 58.60 | 59.90 | 64.20 |
Diluted EPS Before Non-Recurring Items | 20.88 | 17.92 | 13.54 | 10.67 | 11.57 |
Diluted Net EPS (GAAP) | 18.77 | 13.55 | 11.25 | 11.23 | 11.47 |
Fiscal Year end for Molina Healthcare, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 9,880.00 | 9,931.00 | 9,048.00 | 8,548.00 | 8,327.00 |
Cost Of Goods | 8,368.00 | 8,414.00 | 7,454.00 | 7,306.00 | 7,038.00 |
Gross Profit | 1,512.00 | 1,517.00 | 1,594.00 | 1,242.00 | 1,289.00 |
SG&A, R&D, and Dept/Amort Expenses | 1,078.00 | 1,091.00 | 1,278.00 | 883.00 | 846.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 434.00 | 426.00 | 316.00 | 359.00 | 443.00 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 28.00 | 27.00 | 27.00 | 27.00 | 27.00 |
Pretax Income | 406.00 | 399.00 | 289.00 | 332.00 | 416.00 |
Income Taxes | 105.00 | 98.00 | 73.00 | 87.00 | 107.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 301.00 | 301.00 | 216.00 | 245.00 | 309.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 301.00 | 301.00 | 216.00 | 245.00 | 309.00 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 58.20 | 58.30 | 58.20 | 58.10 | 57.90 |
Diluted EPS Before Non-Recurring Items | 5.86 | 5.73 | 4.38 | 5.05 | 5.65 |
Diluted Net EPS (GAAP) | 5.17 | 5.17 | 3.69 | 4.21 | 5.35 |